Dr. Yazdian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1211 Medical Center Dr
Nashville, TN 37232
Education & Training
Vanderbilt University Medical CenterFellowship, Gastroenterology, 2023 - 2026
Temple University HospitalResidency, Internal Medicine, 2020 - 2023
Meharry Medical CollegeClass of 2020
Certifications & Licensure
PA State Medical License 2020 - 2023- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 4 citationsClinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.Bashkim Kadriu, Shiwen Yuan, Cristan Farmer, Allison C. Nugent, Marc S. Lener
Journal of Clinical Psychopharmacology. 2018-06-01 - 2 citationsAtypical Causes of Gastroparesis: Prevalence, Gastric Emptying, and Clinical Features.Lauren Szeto, Aaron Yazdian, Henry P Parkman
Journal of Clinical Gastroenterology. 2023-10-01 - 1 citationsOccult Pulmonary Neuroendocrine Tumor Causing Severe Hyperparathyroidism: Diagnostic Challenges and Clinical Outcomes.Aaron Yazdian, Jeffrey Minuk, Gregory Hemenway, Neelam Upadhyaya, Cherie Lisa Vaz
AACE Clinical Case Reports. 2022-06-18
Journal Articles
- Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to IntolerabilityKadriu B., Yuan S., Farmer C., Nugent A.C., Lener M.S., Niciu M.J., Park M., Yazdian A.L., Ballard E.D., Henn F.A., Henter I.D., Park L.T., Zarate C.A, J Clin Psychopharmacol, 6/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
